- RevelAi Health and Zimmer Biomet announce a multi-year co-marketing agreement.
- The partnership aims to commercialize generative AI-powered solutions for value-based orthopedic care.
- Zimmer Biomet will lead the commercialization efforts of RevelAi Health’s patient care-management platform and other offerings.
- RevelAi Health specializes in AI population health solutions, meeting CMS requirements and enhancing patient engagement.
- The collaboration seeks to address socio-demographic disparities and optimize value-based outcomes.
Main AI News:
In a strategic move poised to revolutionize orthopedic care, RevelAi Health and Zimmer Biomet Holdings, Inc., a prominent player in global medical technology, have inked a multi-year co-marketing pact. This collaboration aims to bring to market cutting-edge generative artificial intelligence (AI) tools tailored to advance value-based orthopedic care and promote health equity. Under the terms of this agreement, Zimmer Biomet will spearhead the commercialization efforts of RevelAi Health’s groundbreaking patient care-management platform, alongside the care team dashboard for healthcare providers, and any forthcoming offerings.
“The fusion of generative AI with clinical workflows represents a pivotal opportunity to foster equitable value-based outcomes,” emphasized Christian Péan MD, MS, CEO of RevelAi Health, and an esteemed orthopedic trauma surgeon at Duke University School of Medicine. “Our AI-driven asynchronous care model not only streamlines patient care processes but also addresses socio-demographic disparities, ensuring personalized, timely, and efficacious care delivery while mitigating clinician burnout. Collaborating with Zimmer Biomet marks a significant stride toward ensuring universal access to quality care.”
RevelAi Health, a trailblazing software as a service (SAAS) health tech firm, specializes in state-of-the-art generative AI population health solutions. At the core of its offerings lies a clinician-validated large language model, empowering healthcare providers to seamlessly transition to value-based care paradigms, in alignment with crucial CMS (Centers for Medicare & Medicaid Services) requirements. These include Patient Reported Outcome measures and Social Drivers of Health (SDOH) Screening, crucial components in contemporary healthcare delivery.
Furthermore, RevelAi Health’s pioneering patient care management system stands as a testament to innovation, harnessing the power of text messaging and clinician-guided voice agents to optimize care workflows and bolster patient engagement.
“Facilitating accessibility to orthopedic care and offering innovative solutions that cater to both the clinical and social exigencies of our communities are imperative to enhancing health outcomes,” remarked Edmond Davis, Senior Director-Health Equity at Zimmer Biomet. “By joining forces with RevelAi, we amalgamate our cutting-edge technologies and shared mission to address the needs of underserved and vulnerable populations, thereby empowering clinicians to maximize value-based outcomes.“
Conclusion:
The partnership between RevelAi Health and Zimmer Biomet signifies a strategic move towards revolutionizing orthopedic care delivery. By leveraging cutting-edge AI technology, the collaboration not only aims to enhance patient care processes but also addresses socio-demographic disparities, ultimately optimizing value-based outcomes. This alliance signals a significant advancement in the healthcare market, indicating a shift towards more innovative and equitable care solutions.
